191 related articles for article (PubMed ID: 3065728)
21. Release of interleukin-6 in cultured B-chronic lymphocytic leukaemia cells is associated with both activation and cell death via apoptosis.
Büssing A; Stein GM; Stumpf C; Schietzel M
Anticancer Res; 1999; 19(5B):3953-9. PubMed ID: 10628337
[TBL] [Abstract][Full Text] [Related]
22. The effects of interleukin 1 on human B cell activation and proliferation.
Falkoff RJ; Muraguchi A; Hong JX; Butler JL; Dinarello CA; Fauci AS
J Immunol; 1983 Aug; 131(2):801-5. PubMed ID: 6602846
[TBL] [Abstract][Full Text] [Related]
23. Low-molecular weight B cell growth factor (BCGF-12KD) as an autocrine growth factor in B cell chronic lymphocytic leukemia.
Fournier S; Jackson J; Kumar A; King T; Sharma S; Biron G; Rubio M; Delespesse G; Sarfati M
Eur J Immunol; 1992 Jul; 22(7):1927-30. PubMed ID: 1623931
[TBL] [Abstract][Full Text] [Related]
24. Recombinant IL-4 and IFN-gamma activate locomotor capacity in human B lymphocytes.
Wilkinson PC; Islam LN
Immunology; 1989 Jun; 67(2):237-43. PubMed ID: 2502496
[TBL] [Abstract][Full Text] [Related]
25. B cell differentiation and interleukin 2 (IL2): corticosteroids interact with monocytes to enhance the effect of IL2.
Emilie D; Karray S; Crevon MC; Vazquez A; Galanaud P
Eur J Immunol; 1987 Jun; 17(6):791-5. PubMed ID: 3109924
[TBL] [Abstract][Full Text] [Related]
26. Interferon-alpha can synergize with interleukin 2 for human in vitro antibody response.
Delfraissy JF; Wallon C; Galanaud P
Eur J Immunol; 1988 Sep; 18(9):1379-84. PubMed ID: 3262520
[TBL] [Abstract][Full Text] [Related]
27. Interleukin 4 induces synthesis of IgE and IgG4 in human B cells.
Lundgren M; Persson U; Larsson P; Magnusson C; Smith CI; Hammarström L; Severinson E
Eur J Immunol; 1989 Jul; 19(7):1311-5. PubMed ID: 2788092
[TBL] [Abstract][Full Text] [Related]
28. Modulation of apoptosis with cytokines in B-cell chronic lymphocytic leukaemia.
Mainou-Fowler T; Prentice AG
Leuk Lymphoma; 1996 May; 21(5-6):369-77. PubMed ID: 9172801
[TBL] [Abstract][Full Text] [Related]
29. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.
Fluckiger AC; Brière F; Zurawski G; Bridon JM; Banchereau J
Immunology; 1994 Nov; 83(3):397-403. PubMed ID: 7530690
[TBL] [Abstract][Full Text] [Related]
30. Human interferon-gamma acts as a B cell growth factor in the anti-IgM antibody co-stimulatory assay but has no direct B cell differentiation activity.
Defrance T; Aubry JP; Vanbervliet B; Banchereau J
J Immunol; 1986 Dec; 137(12):3861-7. PubMed ID: 3097134
[TBL] [Abstract][Full Text] [Related]
31. Diminished DNA synthesis in T cells from B chronic lymphocytic leukemia after phytohemagglutinin, anti-CD3, and phorbol myristate acetate mitogenic signals.
Prieto A; Garcia-Suarez J; Reyes E; Lapeña P; Hernandez M; Alvarez-Mon M
Exp Hematol; 1993 Nov; 21(12):1563-9. PubMed ID: 8405237
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-12 stimulates B cell growth by inducing IFN-gamma.
Li L; Young D; Wolf SF; Choi YS
Cell Immunol; 1996 Mar; 168(2):133-40. PubMed ID: 8640858
[TBL] [Abstract][Full Text] [Related]
33. Comparative activation requirements of human peripheral blood, spleen, and lymph node B cells.
Jelinek DF; Lipsky PE
J Immunol; 1987 Aug; 139(4):1005-13. PubMed ID: 3112218
[TBL] [Abstract][Full Text] [Related]
34. Differentiation factors for human specific B cell response.
Vazquez A; Gerard JP; Delfraissy JF; Dugas B; Auffredou MT; Crevon MC; Fradelizi D; Galanaud P
Eur J Immunol; 1986 Jul; 16(7):803-8. PubMed ID: 3487460
[TBL] [Abstract][Full Text] [Related]
35. Enhancing effects of interleukin 2-treated peripheral blood mononuclear cells on subsequent B cell differentiation.
Stohl W; Elliott JE; Wang H; Lin YG; Horwitz DA
Cell Immunol; 1994 Sep; 157(2):381-92. PubMed ID: 8069923
[TBL] [Abstract][Full Text] [Related]
36. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
Bojarska-Junak A; Rolinski J; Wasik-Szczepaneko E; Kaluzny Z; Dmoszynska A
Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662
[TBL] [Abstract][Full Text] [Related]
37. Direct cellular interaction with activated CD4(+) T cells overcomes hyporesponsiveness of B-cell chronic lymphocytic leukemia in vitro.
Tretter T; Schuler M; Schneller F; Brass U; Esswein M; Aman MJ; Huber C; Peschel C
Cell Immunol; 1998 Oct; 189(1):41-50. PubMed ID: 9758693
[TBL] [Abstract][Full Text] [Related]
38. Proliferative response of B chronic lymphocytic leukemia lymphocytes stimulated with IL2 and soluble CD23.
Brizard A; Morel F; Lecron JC; Dreyfus B; Brizard F; Barra A; Preud'homme JL
Leuk Lymphoma; 1994 Jul; 14(3-4):311-8. PubMed ID: 7950920
[TBL] [Abstract][Full Text] [Related]
39. Effects of tumour necrosis factor and alpha interferon on chronic B cell malignancies.
Bianchi AC; Heslop HE; Drexler HG; Cordingley FT; Turner M; De Mel WC; Hoffbrand AV; Brenner MK
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):317-9. PubMed ID: 3265501
[TBL] [Abstract][Full Text] [Related]
40. CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
de Totero D; Tazzari PL; Capaia M; Montera MP; Clavio M; Balleari E; Foa R; Gobbi M
Haematologica; 2003 Feb; 88(2):148-58. PubMed ID: 12604404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
